Keywords: fda, panel, backs, merck, chickenpox, vaccine, co

FDA PANEL BACKS MERCK CHICKENPOX VACCINE

Article | 07 February 1994

Print This

Merck & Co's Varivax chickenpox vaccine is safe and effective for the short-term protection of children, but the long-term efficacy of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in